Pharma Network for Track-and-Trace and Counterfeit Prevention

Case studies

WMS

Pharma Network for Track-and-Trace and Counterfeit Prevention

Case study of Boehringer Ingelheim's SAP Cloud Platform-based pharma network that enables end-to-end traceability and counterfeit drug detection across the supply chain.

Published

June 4, 2026

Read time

3 min read

Source

SAP

Boehringer Ingelheim implemented a digital collaboration hub using SAP Cloud Platform to connect manufacturers, logistics providers, wholesalers, pharmacies, and hospitals. The network delivers detailed track-and-trace data that allows supply chain participants to verify product authenticity and comply with traceability regulations. Results include faster partner onboarding, reduced transaction costs, and improved regulatory responsiveness.

Key takeaways

Digital network links all pharmaceutical supply chain participants for real-time data exchange

Track-and-trace capabilities help pharmacies and hospitals identify and reject counterfeit products

SAP Cloud Platform Integration service simplifies secure onboarding of new partners

Solution supports compliance with legislation requiring full pharmaceutical traceability

Reduced transaction costs and faster response to regulatory changes

Market overview

SCR methodology note

Vendor landscape

Leaders

Implementation considerations

Important consideration

Original Source

Vendors mentioned in this report

No items found.